SerenaGroup

What SerenaGroup does

SerenaGroup is a private US healthcare company specializing in wound care clinical research and Hyperbaric Oxygen Therapy (HBOT) consulting. Founded by Dr. Thomas Serena, the company operates a network of 23 dedicated wound care research sites across the United States and has accumulated more than 25 years of experience, including 400 peer-reviewed publications, 200 clinical trials, and 2,500 global lectures. SerenaGroup conducts multicenter clinical trials for major pharmaceutical and medical device companies, with recent notable work including the CAMPX randomized controlled trial for Applied Biologics' XWRAP product in chronic diabetic foot ulcers.

The company's business model rests on three professional services revenue streams: clinical research services for industry sponsors, à la carte HBOT consulting for hospitals (covering physician training, accreditation, operational strategy, and compliance), and educational services delivered through a member portal and physician community. Go-to-market is enterprise field sales targeting pharmaceutical/device sponsors and hospital systems, supplemented by industry conference presence and clinical trial enrollment through the corporate website. Operations are concentrated in a single US headquarters in Cambridge, MA, with no disclosed international footprint.

Ownership remains founder-led with no disclosed institutional investors, parent companies, or secondary transactions, and the firm has not raised outside funding rounds based on available data. The core technology is process- and expertise-driven (clinical trial execution, wound healing protocols, HBOT operational know-how) rather than software- or AI-driven, with no disclosed API, integrations, or proprietary algorithms. Revenue, pricing, and headcount trend data are not publicly disclosed.

Name

SerenaGroup

Legal name

SerenaGroup

Website

https://serenagroupinc.com

Company type

Private

Operating status

Operating

Headcount range

101–250 employees

Short description

SerenaGroup is a US wound care clinical research organization operating 23 research sites, conducting clinical trials for pharmaceutical and device sponsors and providing HBOT consulting and educational services to hospitals and physicians.

Ownership category

akta.pro rank

Product category

Wound Care Clinical Research Services

NAICS

Medical and Diagnostic Laboratories (6215), Individual and Family Services (6241)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Misc Health & Allied Services, Nec (8090), Services-Health Services (8000)

akta.pro primary industry

Transcriptomics & Gene Expression Profiling Services (HLAGANAE)

Keywords

• Wound care clinical trials
• Hyperbaric oxygen therapy consulting
• Clinical research organization services
• Wound healing research
• Hospital wound care programs

Headquarters

HQ city

Cambridge

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Revenue model

1. Clinical Research Services: Conducting clinical trials for major pharmaceutical and device companies, providing research services to support product development and regulatory approvals.
2. HBOT Consulting Services: Consulting services to hospitals including physician training, accreditation guidance, operational strategy, and compliance support offered on an à la carte basis.
3. Educational Services: Educational services for wound care professionals including member resources and physician community programs.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

SerenaGroup is a clinical research organization specializing in wound care that conducts multicenter clinical trials for pharmaceutical and medical device companies across a network of 23 U.S. research sites. It supplements this core research service with a national Hyperbaric Oxygen Therapy (HBOT) consulting service that helps hospitals build internal wound care expertise, along with physician training, accreditation guidance, compliance support, and educational resources.

Product overview

SerenaGroup is a clinical research organization specializing in wound care, offering a platform of integrated services including clinical research trial management, educational services, hyperbaric oxygen therapy consulting, member resources, compliance support, and physician community programs. The company operates 23 research sites across the United States and partners with industry leaders, healthcare providers, and academic institutions to advance wound healing science. The core offering consists of clinical research services for conducting wound care trials, supplemented by specialized consulting services like the recently launched national HBOT Consulting Service, along with educational and compliance modules for healthcare providers.

Differentiator

Problem solved

Functional benefit

Products and services

• Clinical Research Services Comprehensive clinical research services supporting wound care trials for pharmaceutical and medical device sponsors, enabling healthcare providers to integrate cutting-edge clinical research into their workflow and offer patients access to advanced wound care treatments across SerenaGroup's U.S. research site network.
• HBOT Consulting Service National consulting service that helps hospitals build internal wound care expertise and reduce reliance on outsourced management models, offering physician training, accreditation guidance, operational strategy, and compliance support on an à la carte basis.

Quantifiable outcome

• CAMPX Trial: 31% of patients achieved complete wound closure with XWRAP vs 18% for standard of care (p=0.023)
• +1 more outcomes

Named customers1 record

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• Applied BiologicscoreStrategic or Co-development Partner · 15 June 2026SerenaGroup conducted the CAMPX randomized controlled clinical trial evaluating Applied Biologics' XWRAP product for chronic diabetic foot ulcers. The trial was conducted across 23 SerenaGroup research sites throughout the United States, enrolling approximately 160 patients. This represents a strategic research partnership for product clinical evaluation.

Scale indicators6 records

Recent moves5 records

Expansion highlights4 records

Direct peers

• Healogics: Largest US wound care management and clinical research organization, operating wound care centers and running wound-related clinical trials. Most directly comparable specialty wound care CRO and program operator to SerenaGroup.
• Worldwide Clinical Trials: Mid-sized global CRO focused on complex therapeutic areas and specialty indications. Comparable as a therapeutically specialized CRO that competes for the same sponsor trial mandates.

Broad incumbents

• Medpace: Mid-to-large global CRO with therapeutic-area specialization and full-service clinical trial execution. Comparable as a CRO peer, though not wound-care-specific, and operates at meaningfully larger scale.
• IQVIA: World's largest CRO and clinical research services provider with deep therapeutic-area coverage including wound care. Comparable as the dominant incumbent competitor for sponsor-funded trial work.
• Smith+Nephew: Global medical device company with a major Advanced Wound Management franchise. Comparable as both a potential sponsor of wound care trials and a broad incumbent shaping the wound care market.
• ConvaTec: Global medical products company with a leading Advanced Wound Care portfolio. Comparable as a sponsor-side customer and adjacent incumbent in the wound care space SerenaGroup serves.
• Integra LifeSciences: Medical technology company with wound care and regenerative tissue products. Comparable as a potential sponsor of wound-related trials and an established incumbent in wound care.
• Labcorp Drug Development (now Fortrea): Large global CRO spun out of Labcorp, offering full-service clinical development. Comparable as a generalist incumbent competitor for sponsor-funded wound care trials.

Emerging players

• Organogenesis: Commercial-stage wound care biologics company (e.g., Apligraf, Dermagraft) that is both a potential sponsor of SerenaGroup-style trials and a downstream competitor in the wound care value chain.
• MiMedx: Wound care and surgical recovery biologics company. Comparable as a sponsor of wound care clinical trials and an adjacent commercial player in the same therapeutic ecosystem.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/SerenaGroup4

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SerenaGroup